NorB, an Efflux Pump in Staphylococcus aureus Strain MW2, Contributes to Bacterial Fitness in Abscesses

被引:114
|
作者
Ding, Yanpeng [1 ]
Onodera, Yoshikuni [1 ]
Lee, Jean C. [2 ]
Hooper, David C. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Infect Dis, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1128/JB.00655-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
While remaining a major problem in hospitals, Staphylococcus aureus is now spreading in communities. Strain MW2 (USA400 lineage) and other community methicillin-resistant S. aureus strains most commonly cause skin infections with abscess formation. Multidrug resistance (MDR) efflux pumps contribute to antimicrobial resistance but may also contribute to bacterial survival by removal of environmental toxins. In S. aureus, NorA, NorB, NorC, and Tet38 are chromosomally encoded efflux pumps whose overexpression can confer MDR to quinolones and other compounds (Nor pumps) or tetracyclines alone (Tet38), but the natural substrates of these pumps are not known. To determine the role of these efflux pumps in a natural environment in the absence of antibiotics, we used strain MW2 in a mouse subcutaneous abscess model and compared pump gene expression as determined by reverse transcription-PCR in the abscesses and in vitro. norB and tet38 were selectively upregulated in vivo more than 171- and 24-fold, respectively, whereas norA and norC were down-regulated. These changes were associated with an increase in expression of mgrA, which encodes a transcriptional regulator known to affect pump gene expression. In competition experiments using equal inocula of a norB or tet38 mutant and parent strain MW2, each mutant exhibited growth defects of about two- to threefold in vivo. In complementation experiments, a single-copy insertion of norB (but not a single-copy insertion of tet38) in the attB site within geh restored the growth fitness of the norB mutant in vivo. Our findings indicate that some MDR pumps, like NorB, can facilitate bacterial survival when they are overexpressed in a staphylococcal abscess and may contribute to the relative resistance of abscesses to antimicrobial therapy, thus linking bacterial fitness and resistance in vivo.
引用
收藏
页码:7123 / 7129
页数:7
相关论文
共 39 条
  • [31] Identification of the plasmid-encoded qacA efflux pump gene in meticillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone
    Costa, S. S.
    Ntokou, E.
    Martins, A.
    Viveiros, M.
    Pournaras, S.
    Couto, I.
    Amaral, L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (06) : 557 - 561
  • [32] Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations
    Palazzotti, Deborah
    Felicetti, Tommaso
    Sabatini, Stefano
    Moro, Stefano
    Barreca, Maria Letizia
    Sturlese, Mattia
    Astolfi, Andrea
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (15) : 4875 - 4887
  • [33] Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors
    Sabatini, Stefano
    Gosetto, Francesca
    Serritella, Serena
    Manfroni, Giuseppe
    Tabarrini, Oriana
    Iraci, Nunzio
    Brincat, Jean Pierre
    Carosati, Emanuele
    Villarini, Milena
    Kaatz, Glenn W.
    Cecchetti, Violetta
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3568 - 3572
  • [34] Green Synthesis of CuFe2O4@Ag Nanocomposite Using the Chlorella vulgaris and Evaluation of its Effect on the Expression of norA Efflux Pump Gene Among Staphylococcus aureus Strains
    Kahzad, Nakisa
    Salehzadeh, Ali
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 198 (01) : 359 - 370
  • [35] Green Synthesis of CuFe2O4@Ag Nanocomposite Using the Chlorella vulgaris and Evaluation of its Effect on the Expression of norA Efflux Pump Gene Among Staphylococcus aureus Strains
    Nakisa Kahzad
    Ali Salehzadeh
    Biological Trace Element Research, 2020, 198 : 359 - 370
  • [36] Re-evolution of the 2-Phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance
    Sabatini, Stefano
    Gosetto, Francesca
    Iraci, Nunzio
    Barreca, Maria Letizia
    Massari, Serena
    Sancineto, Luca
    Manfroni, Giuseppe
    Tabarrini, Oriana
    Dimovska, Mirjana
    Kaatz, Glenn W.
    Cecchetti, Violetta
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (12) : 4975 - 4989
  • [37] Molecular docking and antibacterial and antibiotic-modifying activities of synthetic chalcone (2E)-1-(3′-aminophenyl)-3-(4-dimethylaminophenyl)-prop-2-en-1-one in a MepA efflux pump-expressing Staphylococcus aureus strain
    da Silva, Larissa
    Goncalves, Cicera Alane Coelho
    Bezerra, Antonio Henrique
    dos Santos Barbosa, Cristina Rodrigues
    Rocha, Janaina Esmeraldo
    de Matos, Yedda Maria Lobo Soares
    de Oliveira, Ligia Claudia Castro
    dos Santos, Helcio Silva
    Coutinho, Henrique Douglas Melo
    da Cunha, Francisco Assis Bezerra
    FOLIA MICROBIOLOGICA, 2024,
  • [38] Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl) acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus
    Rath, Santosh K.
    Singh, Samsher
    Kumar, Sunil
    Wani, Naiem A.
    Rai, Rajkishor
    Koul, Surrinder
    Khan, Inshad A.
    Sangwan, Payare L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (02) : 343 - 353
  • [39] Synthesis, spectroscopic characterization, and antibacterial activity of chalcone (2E)-1-(3′-aminophenyl)-3-(4-dimethylaminophenyl)-prop-2-en-1-one against multiresistant Staphylococcus aureus carrier of efflux pump mechanisms and β-lactamase
    da Silva, Larissa
    Donato, Isydorio Alves
    Bezerra, Suieny Rodrigues
    dos Santos, Helcio Silva
    Bandeira, Paulo Nogueira
    do Nascimento, Maria Thalia Ramos
    Guedes, Jesyka Macedo
    Freitas, Priscila Ramos
    de Araujo, Ana Carolina Justino
    de Freitas, Thiago Sampaio
    Coutinho, Henrique Douglas Melo
    de Matos, Yedda Maria Lobo Soares
    de Oliveira, Ligia Claudia Castro
    da Cunha, Francisco Assis Bezerra
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (01) : 60 - 71